Log in

CymaBay Therapeutics News Headlines (NASDAQ:CBAY)

$4.52
+0.21 (+4.87 %)
(As of 10/13/2019 04:00 PM ET)
Today's Range
$4.34
Now: $4.52
$4.65
50-Day Range
$4.25
MA: $5.53
$6.40
52-Week Range
$4.23
Now: $4.52
$14.00
Volume1.07 million shs
Average Volume635,443 shs
Market Capitalization$310.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Headlines

CymaBay Therapeutics (NASDAQ CBAY) News Headlines

Source:
DateHeadline
-$0.37 Earnings Per Share Expected for CymaBay Therapeutics Inc (NASDAQ:CBAY) This Quarter-$0.37 Earnings Per Share Expected for CymaBay Therapeutics Inc (NASDAQ:CBAY) This Quarter
www.americanbankingnews.com - October 3 at 1:19 AM
CymaBay presenting two abstracts at Liver MeetingCymaBay presenting two abstracts at Liver Meeting
seekingalpha.com - October 1 at 5:19 PM
CymaBay Therapeutics Announces Presentations at The Liver Meeting(R) 2019CymaBay Therapeutics Announces Presentations at The Liver Meeting(R) 2019
www.marketwatch.com - October 1 at 5:19 PM
CymaBay Therapeutics Announces Presentations at The Liver Meeting® 2019CymaBay Therapeutics Announces Presentations at The Liver Meeting® 2019
finance.yahoo.com - October 1 at 5:19 PM
CymaBay Therapeutics to Present at the 2019 Cantor Global Healthcare ConferenceCymaBay Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 30 at 8:19 AM
Investors Who Bought CymaBay Therapeutics (NASDAQ:CBAY) Shares Three Years Ago Are Now Up 168%Investors Who Bought CymaBay Therapeutics (NASDAQ:CBAY) Shares Three Years Ago Are Now Up 168%
finance.yahoo.com - September 28 at 3:55 PM
CymaBay Therapeutics Inc (NASDAQ:CBAY) Given Average Recommendation of "Buy" by AnalystsCymaBay Therapeutics Inc (NASDAQ:CBAY) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - September 28 at 2:46 AM
FY2020 EPS Estimates for CymaBay Therapeutics Inc (NASDAQ:CBAY) Lifted by B. RileyFY2020 EPS Estimates for CymaBay Therapeutics Inc (NASDAQ:CBAY) Lifted by B. Riley
www.americanbankingnews.com - September 26 at 7:46 AM
Sujal Shah Purchases 5,000 Shares of CymaBay Therapeutics Inc (NASDAQ:CBAY) StockSujal Shah Purchases 5,000 Shares of CymaBay Therapeutics Inc (NASDAQ:CBAY) Stock
www.americanbankingnews.com - September 24 at 12:25 PM
CymaBay Therapeutics Inc (NASDAQ:CBAY) CEO Acquires $10,450.00 in StockCymaBay Therapeutics Inc (NASDAQ:CBAY) CEO Acquires $10,450.00 in Stock
www.americanbankingnews.com - September 24 at 12:25 PM
CymaBay Therapeutics (NASDAQ:CBAY) PT Set at $20.00 by Cantor FitzgeraldCymaBay Therapeutics (NASDAQ:CBAY) PT Set at $20.00 by Cantor Fitzgerald
www.americanbankingnews.com - September 20 at 8:17 PM
CymaBay Therapeutics Announces Departure of Chief Medical OfficerCymaBay Therapeutics Announces Departure of Chief Medical Officer
finance.yahoo.com - September 17 at 5:28 PM
Investors in CymaBay Therapeutics Need Patience and DisciplineInvestors in CymaBay Therapeutics Need Patience and Discipline
finance.yahoo.com - September 17 at 5:24 AM
What You Must Know About CymaBay Therapeutics, Inc.'s (NASDAQ:CBAY) Beta ValueWhat You Must Know About CymaBay Therapeutics, Inc.'s (NASDAQ:CBAY) Beta Value
finance.yahoo.com - August 23 at 4:29 PM
Edited Transcript of CBAY earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of CBAY earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 9 at 9:41 PM
CymaBay Therapeutics, Inc. (CBAY) Q2 2019 Earnings Call TranscriptCymaBay Therapeutics, Inc. (CBAY) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 4:41 PM
Notable Thursday Option Activity: CBAY, NVRO, PXDNotable Thursday Option Activity: CBAY, NVRO, PXD
www.nasdaq.com - August 8 at 4:55 PM
CymaBay Therapeutics EPS beats by $0.02CymaBay Therapeutics EPS beats by $0.02
seekingalpha.com - August 7 at 4:40 PM
CymaBay Reports Second Quarter 2019 Financial Results and Provides Corporate UpdateCymaBay Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 7 at 4:40 PM
CymaBay Therapeutics Strengthens Management Team with Appointment of Janet Dorling as Chief Commercial OfficerCymaBay Therapeutics Strengthens Management Team with Appointment of Janet Dorling as Chief Commercial Officer
finance.yahoo.com - August 5 at 10:49 AM
CymaBay Therapeutics to Report Second Quarter 2019 Financial Results on Wednesday, August 7CymaBay Therapeutics to Report Second Quarter 2019 Financial Results on Wednesday, August 7
finance.yahoo.com - July 31 at 9:16 PM
Stifel likes Viking Therapeutics in premarket analyst actionStifel likes Viking Therapeutics in premarket analyst action
seekingalpha.com - June 25 at 8:32 AM
CymaBay +2.8% on new Buy rating at StifelCymaBay +2.8% on new Buy rating at Stifel
seekingalpha.com - June 24 at 7:04 PM
CymaBay Tumbles On NASH Data, But One Must Take A Closer Look To Get The Full PictureCymaBay Tumbles On NASH Data, But One Must Take A Closer Look To Get The Full Picture
seekingalpha.com - June 18 at 7:31 PM
CymaBay wins IND for seladelpar study to treat primary sclerosing cholangitisCymaBay wins IND for seladelpar study to treat primary sclerosing cholangitis
seekingalpha.com - June 18 at 7:31 PM
CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar to Treat Primary Sclerosing CholangitisCymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar to Treat Primary Sclerosing Cholangitis
finance.yahoo.com - June 18 at 7:31 PM
Bulls Walk the Market Up Slowly, but Keep One Eye on FedBulls Walk the Market Up Slowly, but Keep One Eye on Fed
finance.yahoo.com - June 17 at 4:34 PM
CymaBay Therapeutics to Participate in the Raymond James Life Sciences and MedTech ConferenceCymaBay Therapeutics to Participate in the Raymond James Life Sciences and MedTech Conference
www.marketwatch.com - June 17 at 12:30 PM
What’s Been Dragging Down CymaBay Therapeutics StockWhat’s Been Dragging Down CymaBay Therapeutics Stock
finance.yahoo.com - June 14 at 6:30 PM
CymaBay Therapeutics: What Investors Should Watch ForCymaBay Therapeutics: What Investors Should Watch For
finance.yahoo.com - June 14 at 6:30 PM
What Analysts Recommend for CBAY and VKTXWhat Analysts Recommend for CBAY and VKTX
finance.yahoo.com - June 14 at 1:28 PM
Intercept Pharmaceuticals, CymaBay’s and Viking’s CompetitorIntercept Pharmaceuticals, CymaBay’s and Viking’s Competitor
finance.yahoo.com - June 14 at 1:28 PM
CymaBay Down on Dismal Interim Data From Mid-Stage NASH StudyCymaBay Down on Dismal Interim Data From Mid-Stage NASH Study
finance.yahoo.com - June 12 at 7:31 PM
CymaBay +4.8% as Raymond James fades 45% sell-offCymaBay +4.8% as Raymond James fades 45% sell-off
seekingalpha.com - June 12 at 2:30 PM
Why Beyond Meat, Lovesac, and CymaBay Therapeutics Slumped TodayWhy Beyond Meat, Lovesac, and CymaBay Therapeutics Slumped Today
www.nasdaq.com - June 12 at 2:30 PM
CymaBay Therapeutics Stock Plunged. Here’s Why It Could Be Time to BuyCymaBay Therapeutics Stock Plunged. Here’s Why It Could Be Time to Buy
www.barrons.com - June 12 at 2:30 PM
Here's Why CymaBay Therapeutics Collapsed TodayHere's Why CymaBay Therapeutics Collapsed Today
finance.yahoo.com - June 11 at 4:27 PM
CymBays pain is Vikings gain, up 9% premarketCymBay's pain is Viking's gain, up 9% premarket
seekingalpha.com - June 11 at 11:36 AM
How Much Are CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Insiders Spending On Buying Shares?How Much Are CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Insiders Spending On Buying Shares?
finance.yahoo.com - June 11 at 11:36 AM
Steven Cohen Takes an Interest in CymaBay TherapeuticsSteven Cohen Takes an Interest in CymaBay Therapeutics
finance.yahoo.com - June 10 at 4:21 PM
CymaBay Therapeutics: Targeting Primary Biliary Cholangitis And Then Onto NASHCymaBay Therapeutics: Targeting Primary Biliary Cholangitis And Then Onto NASH
seekingalpha.com - May 28 at 3:56 PM
Options Traders Expect Huge Moves in CymaBay Therapeutics (CBAY) StockOptions Traders Expect Huge Moves in CymaBay Therapeutics (CBAY) Stock
finance.yahoo.com - May 22 at 11:48 AM
CymaBay Therapeutics Presents Data in Patients with Primary Biliary Cholangitis at DDW 2019CymaBay Therapeutics Presents Data in Patients with Primary Biliary Cholangitis at DDW 2019
finance.yahoo.com - May 20 at 4:30 PM
CymaBay Therapeutics misses by $0.03CymaBay Therapeutics misses by $0.03
seekingalpha.com - May 9 at 11:49 AM
CymaBay Reports First Quarter 2019 Financial Results and Provides Corporate UpdateCymaBay Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 9 at 11:49 AM
Edited Transcript of CBAY earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of CBAY earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 11:49 AM
Report: Developing Opportunities within VEREIT, CareDx, CymaBay Therapeutics, and Harsco - Future Expectations, Projections Moving into 2019Report: Developing Opportunities within VEREIT, CareDx, CymaBay Therapeutics, and Harsco - Future Expectations, Projections Moving into 2019
www.baystreet.ca - May 6 at 11:00 AM
Genfit, Cymbay Hope to Crack Large Liver Disease MarketGenfit, Cymbay Hope to Crack Large Liver Disease Market
finance.yahoo.com - May 2 at 4:20 PM
CymaBay Therapeutics to Report First Quarter 2019 Financial Results on Wednesday, May 8CymaBay Therapeutics to Report First Quarter 2019 Financial Results on Wednesday, May 8
finance.yahoo.com - April 30 at 11:27 AM
CymaBay And Seladelpar In NASH: The MomentCymaBay And Seladelpar In NASH: The Moment
seekingalpha.com - April 26 at 4:00 PM
This page was last updated on 10/13/2019 by MarketBeat.com Staff

Featured Article: Dead Cat Bounce

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel